Yuh-Ing Junior College of Health Care and Management, Kaohsiung, Taiwan.
Neurourol Urodyn. 2013 Nov;32(8):1137-43. doi: 10.1002/nau.22367. Epub 2013 Jan 28.
The aims of the present study were to investigate voiding patterns, tissue constituents and the expressions of cyclooxygenase-2 (COX-2) and nitric oxide synthase (NOS) involved in ketamine-induced ulcerative cystitis in rat urinary bladder.
Thirty Sprague-Dawley rats were distributed into three groups which received saline or ketamine (25 mg/kg/day) for a period of 14 and 28 days. In each group, cystometry was performed weekly and the concentration of ketamine and its metabolites (norketamine) was assayed. Paraffin-embedded sections were stained with Masson's trichrome stain, and ketamine-induced morphological changes were examined. Western blot analyses were carried out to examine the expressions of COX-2 and different NOS isoforms in bladder tissues. Immunofluorescence study was done to evaluate the expressions of COX-2 and macrophage infiltration (stained with ED-1 macrophage cell surface antigen) within the bladder.
Ketamine treatment resulted in bladder hyperactivity and the non-voiding contractions were significantly increased. The urine concentrations of ketamine and norketamine were much higher in ketamine-treated group. Moreover, ulcerated urothelium and mononuclear cell infiltration were noted in ketamine-treated group. These alterations in urodynamic functions and tissue constituents were accompanied by increases in the expression of COX-2. Two NOS isoforms (iNOS and eNOS) were also overexpressed, but no significant change was observed for nNOS. COX-2 positive stained cells were significantly increased. Meanwhile, increased amounts of ED-1 positive stained macrophages were present and most of COX-2 expressed cells were co-stained with ED-1 in the early stage of ketamine treatment.
Ketamine treatment affected bladder tissues by enhancing interstitial fibrosis and accelerating macrophages infiltration. Ketamine also initiated the up-regulations of COX-2 and iNOS and eNOS expressions. These up-regulated enzymes might play an important role in contributing to ketamine-induced alterations in micturition patterns and ulcerative cystitis.
本研究旨在探讨氯胺酮诱导的大鼠膀胱溃疡性膀胱炎中与环氧化酶-2(COX-2)和一氧化氮合酶(NOS)相关的排尿模式、组织成分及表达。
30 只 Sprague-Dawley 大鼠随机分为三组,分别给予生理盐水或氯胺酮(25mg/kg/天)14 天和 28 天。每组每周进行一次膀胱测压,测定氯胺酮及其代谢物(去甲氯胺酮)的浓度。用 Masson 三色染色法对石蜡包埋切片进行染色,观察氯胺酮诱导的形态学变化。采用 Western blot 分析检测膀胱组织中 COX-2 和不同 NOS 同工型的表达。免疫荧光染色评估 COX-2 和巨噬细胞浸润(用 ED-1 巨噬细胞表面抗原染色)在膀胱内的表达。
氯胺酮治疗导致膀胱过度活动,非排尿性收缩明显增加。氯胺酮治疗组的尿中氯胺酮和去甲氯胺酮浓度明显升高。此外,氯胺酮治疗组还观察到溃疡性尿路上皮和单核细胞浸润。这些尿动力学功能和组织成分的改变伴随着 COX-2 表达的增加。两种 NOS 同工型(iNOS 和 eNOS)也过度表达,但 nNOS 无明显变化。COX-2 阳性染色细胞明显增加。同时,有大量的 ED-1 阳性染色巨噬细胞存在,并且在氯胺酮治疗的早期,大部分 COX-2 表达细胞与 ED-1 共染色。
氯胺酮治疗通过增强间质纤维化和加速巨噬细胞浸润来影响膀胱组织。氯胺酮还启动了 COX-2 和 iNOS 及 eNOS 表达的上调。这些上调的酶可能在导致氯胺酮引起的排尿模式改变和溃疡性膀胱炎中发挥重要作用。